What Is Abnormal Myocardial Perfusion?

Abnormal myocardial perfusion means that some part of your heart muscle is not receiving adequate blood flow, either at rest or when the heart is under stress. The finding typically shows up on imaging tests designed to map how blood distributes across the heart wall, and it serves as one of the strongest indicators that coronary artery disease or another vascular problem is limiting oxygen delivery to the muscle that keeps you alive. But “abnormal” on a perfusion scan does not automatically mean a blocked artery, and the gap between what the images show and what is actually happening in the coronary vessels is where much of the nuance lives.

How Blood Reaches the Heart Muscle

Your heart pumps blood to every organ in the body, but it also needs its own dedicated supply. That supply arrives through the coronary arteries, which branch off the aorta and divide into progressively smaller vessels that penetrate the heart wall. The smallest of these, the microvessels, are where oxygen actually transfers into heart muscle cells. When everything works, blood flow ramps up dramatically during exercise or emotional stress to match increased demand. Myocardial perfusion imaging exploits that principle: it compares blood flow at rest with blood flow under stress. If a region falls behind during stress, that region shows up as a defect on the scan.

The stress itself can be produced by actual exercise on a treadmill or by a drug that mimics the effect of exercise on the coronary vessels. A head-to-head comparison found that drug-based stress testing picked up more territory at risk than exercise testing, particularly in patients with disease in multiple coronary arteries, where the odds of a meaningful discrepancy between the two methods were about nine times higher.

What the Imaging Tests Actually Measure

Several technologies can map myocardial perfusion, each with trade-offs in accuracy, radiation dose, availability, and cost. The two nuclear medicine workhorses are SPECT and PET. Both involve injecting a small amount of radioactive tracer into the bloodstream and then capturing images of how the tracer distributes through the heart muscle.

SPECT is the most widely available perfusion test worldwide. A meta-analysis examining its diagnostic accuracy for coronary artery disease found that when attenuation correction was applied, pooled sensitivity reached about 84% and specificity about 80%.¹ Without attenuation correction, specificity dropped to around 68%, meaning more false alarms. Those false alarms matter because they can lead to unnecessary invasive procedures.

PET offers several advantages over SPECT. It delivers higher image quality, exposes you to less radiation because the tracers decay faster, and, crucially, it can measure blood flow in absolute terms, expressed as milliliters of blood per minute per gram of tissue.² That absolute measurement lets doctors calculate something called myocardial flow reserve, which is the ratio of blood flow during maximum stress to blood flow at rest. A study using PET showed that flow reserve could reliably distinguish between coronary lesions of intermediate severity, separating arteries that were 50–70% narrowed from those that were 70–90% narrowed.³

Cardiac MRI offers yet another approach. Quantitative first-pass perfusion MRI has been shown to outperform visual analysis in detecting areas of reduced blood flow and in sizing up the ischemic burden, all without any radiation exposure.⁴ And dynamic CT perfusion imaging, a newer technique, adds value on top of standard coronary CT angiography for identifying blockages that are actually limiting flow.⁵

Interpreting the Results

When you get a perfusion scan, the cardiologist or nuclear medicine physician looks at color-coded maps of your heart muscle under stress and at rest. Areas with normal blood flow light up uniformly. Areas that receive less blood during stress but recover at rest suggest ischemia, meaning the muscle is temporarily starved but still viable. Areas that look abnormal both at rest and under stress may indicate scar tissue from a prior heart attack, where the muscle has died and been replaced by fibrous tissue.

The size and severity of the defect matter enormously. A small, mild area of reduced uptake in a single segment is a very different finding from a large, severe defect spanning multiple walls of the heart. Scoring systems assign numbers to each segment of the heart, and the summed stress score gives doctors a single number that captures the overall perfusion burden. When quantitative blood flow data from PET is layered on top of these visual scores, diagnostic accuracy improves further. One study found that combining the visual score with absolute blood flow and flow reserve pushed sensitivity from 57% up to 77%, though at the cost of some specificity.⁶

A key distinction for patients to understand: an abnormal perfusion scan tells you that blood flow is uneven, not necessarily that a coronary artery is critically blocked. The test is a functional assessment. Whether the underlying anatomy needs treatment depends on additional evaluation, often including invasive angiography with fractional flow reserve measurement, which is considered the gold standard for deciding whether a particular narrowing is actually limiting blood flow enough to cause harm.⁷

Why Perfusion Can Be Abnormal Without a Major Blockage

Coronary artery disease, meaning cholesterol-laden plaques narrowing the large arteries on the heart’s surface, is the most common reason for abnormal perfusion. But it is far from the only one. The coronary microcirculation, those tiny vessels too small to see on an angiogram, can be diseased in their own right. This condition, called coronary microvascular dysfunction, causes reduced blood flow to the heart muscle despite wide-open large arteries. It is more common in women with chest pain than in men, and it is not a benign finding.⁸ In patients who had chest pain and no obstructive coronary disease, microvascular dysfunction was actually more prevalent in those with completely clean arteries than in those with mild, non-obstructive narrowing.⁹

Coronary vasospasm is another culprit. In these patients, a coronary artery temporarily squeezes shut, choking off blood flow and producing a defect on perfusion imaging that looks like what you would see with a fixed blockage. Reversible defects on stress perfusion scans are frequently present in patients with vasospasm, even when angiography shows normal-looking arteries.¹⁰ Patients with epicardial spasm, where the spasm hits a large surface artery, showed lower perfusion ratios than patients without spasm, while spasm limited to the microvasculature alone did not always produce as clear a signal on imaging.¹¹

Abnormal Perfusion in Cardiomyopathies

Diseases of the heart muscle itself, the cardiomyopathies, routinely produce abnormal perfusion patterns even when no coronary plaque is present. Microvascular dysfunction is strikingly common across these conditions: roughly 50–60% of patients with dilated cardiomyopathy, 40–80% of those with hypertrophic cardiomyopathy, and over 95% of those with cardiac amyloidosis show impaired perfusion.¹² In many cases, perfusion defects appear before the structural changes that define the disease, such as thickening of the wall or scarring, become obvious. That makes perfusion imaging potentially useful for catching these conditions early.

Different cardiomyopathies leave different fingerprints on perfusion scans. Hypertrophic cardiomyopathy tends to produce defects concentrated in the thickened septum, cardiac amyloidosis often shows diffusely reduced uptake, and sarcoidosis can produce patchy defects that do not follow the typical coronary artery territories.¹³ Recognizing these patterns matters because the treatment for cardiomyopathy-related perfusion abnormalities is completely different from the treatment for coronary artery blockages.

PET imaging can also combine perfusion tracers with a glucose analog to map metabolic activity. When a region of heart muscle has low blood flow but is still metabolizing glucose avidly, that mismatch signals hibernating myocardium, muscle that is alive but underperfused. This distinction is critical because hibernating muscle can recover function if blood flow is restored, while truly dead muscle cannot.¹⁴

False Alarms and Imaging Pitfalls

Not every dark spot on a perfusion scan reflects a real problem inside the heart. Artifacts, the imaging equivalent of optical illusions, are a well-known headache in this field. The most common source of false positives on SPECT scans is attenuation, where tissue between the camera and the heart absorbs some of the radioactive signal before it reaches the detector. Breast tissue in women is the single most frequent cause of false-positive planar images.¹⁵ The diaphragm can produce a similar effect on the bottom wall of the heart, particularly in heavier patients.

Body habitus creates problems at the other extreme too. A case report documented a false-positive severe defect at the apex and anteroseptal wall of a very thin patient, caused entirely by the heart drifting to the edge of the camera’s field of view during acquisition, a phenomenon called truncation artifact.¹⁶ Patient motion, gut activity from a recent meal, and even the angle at which a patient is positioned on the table can produce artifacts that mimic real disease. Experienced readers know how to spot these, but they are one of the reasons that automated interpretation tools and attenuation correction methods have become so important.

What Abnormal Perfusion Means for Your Prognosis

This is where the findings become very personal. An abnormal perfusion scan does not just point to a possible blockage; it is one of the strongest predictors of whether you are likely to have a heart attack, need an emergency procedure, or die from heart disease in the coming years. In one study following patients with high exercise tolerance, those with abnormal perfusion imaging had an eight-fold higher risk of cardiac events compared to those with normal scans, while the exercise ECG alone had no predictive power at all.¹⁷

In women specifically, abnormal SPECT perfusion imaging strongly predicted death, with those who had abnormal scans dying at a rate of about 13% compared to 4% in those with normal scans, and the imaging added significant prognostic information beyond what clinical risk factors and heart function measurements could provide.¹⁸

Quantitative flow measurements sharpen the picture further. Research using AI-assisted perfusion mapping on cardiac MRI found that for each unit decrease in myocardial perfusion reserve, the risk of death roughly doubled, with an adjusted hazard ratio of about 2.45. The hazard ratio for major adverse cardiac events was similarly elevated for decreases in stress blood flow.¹⁹ These are not small statistical wrinkles. They represent meaningfully different futures for patients depending on what the perfusion data shows.

Treatment Decisions After an Abnormal Scan

Finding abnormal perfusion sets off a decision tree that can go in very different directions depending on the severity. For mild or moderate abnormalities, the evidence strongly supports starting with aggressive medical therapy: cholesterol-lowering drugs, blood pressure management, antiplatelet medications, and lifestyle changes. The question of whether adding a stent or bypass surgery to that medical therapy actually reduces heart attacks or death has been the subject of intense debate for years.

A review of major trials concluded that patients with stable coronary artery disease and substantial ischemia sit in what researchers have called a state of “community equipoise,” meaning cardiologists genuinely disagree about whether revascularization adds benefit on top of optimal medications.²⁰ That said, preliminary evidence suggests that patients carrying a heavy ischemic burden, meaning a large area of the heart is underperfused, may be the subgroup most likely to benefit from having blood flow physically restored, particularly through coronary artery bypass grafting.²¹

For patients with hibernating myocardium, those perfusion-metabolism mismatch patterns described earlier, the calculus shifts. If a substantial amount of viable but underfed muscle is identified, restoring blood flow can sometimes rescue heart function that appeared to be permanently lost. That is why viability assessment with PET or MRI is often performed before deciding on bypass surgery in patients with weak hearts.

Perfusion Imaging in Children and Congenital Heart Disease

Abnormal myocardial perfusion is not just an adult problem. Children born with structural heart defects can develop perfusion abnormalities for reasons that have nothing to do with cholesterol plaques. In congenital conditions like transposition of the great arteries and tetralogy of Fallot, the right ventricle faces abnormally high pressure and thickens in response. That thickening outstrips the growth of the tiny blood vessels feeding the muscle, producing a mismatch between supply and demand. A study using contrast echocardiography found that patients with these conditions had significantly lower microvascular density and reduced blood flow reserve in the right ventricular septum compared to healthy controls, and the reduced reserve correlated with impaired pumping function.²²

Perfusion MRI has also shown feasibility and clinical promise in children, with good agreement between MRI-based perfusion assessment and both coronary angiography and SPECT in a mixed group of congenital and acquired pediatric heart disease.²³ Because children are especially vulnerable to cumulative radiation exposure over a lifetime, radiation-free techniques like MRI and ultrafast ultrasound are areas of active development for this population.

How Artificial Intelligence Is Changing the Read

Reading perfusion scans is partly subjective, and even experienced cardiologists disagree on borderline cases. Machine learning algorithms are being trained to standardize and improve that interpretation. In a large-population study, a machine learning approach to SPECT perfusion reading achieved overall diagnostic accuracy of about 87%, matching the best human expert and outperforming a second expert reader and traditional automated scoring methods.²⁴

More recent deep learning models have pushed further. An AI-enhanced perfusion scoring system achieved an area under the curve of 0.84 for predicting obstructive coronary disease, significantly outperforming both traditional quantitative scoring alone and the deep learning model alone, suggesting that the combination of human-designed scoring and AI pattern recognition works better than either approach in isolation.²⁵ Another comprehensive study using multiple deep learning architectures on SPECT data found that certain fusion models reached an area under the curve of 0.89 for per-vessel coronary disease detection, and saliency maps showed the models were focusing on the right regions of the heart to make their decisions.²⁶

These tools are not replacing cardiologists. They are acting as a second set of eyes, flagging abnormalities that a tired reader might underplay and helping to standardize interpretation across hospitals that vary widely in the experience level of their nuclear cardiology staff. For patients, this could eventually mean fewer false positives sent for unnecessary catheterizations and fewer true positives missed on a busy reading day.